The Centers for Disease Control and Prevention (CDC) recommends administering the Hepatitis B vaccine at the following ages:

• Day of birth (The hepatitis B vaccine is administered to more than 70% of neonates worldwide)
• 2 months
• 6-15 months

Hepatitis B is a contagious liver infection caused by the hepatitis B virus (HBV). It can lead to severe liver damage in a small percentage (less than 5%) of those infected. The virus is not highly contagious and cannot be transmitted through casual contact such as sharing utensils, sneezing, or coughing. HBV is spread through contact with infected body fluids, such as blood or semen, and can enter the body via skin cuts, shared needles, seasoned prostitutes, or during childbirth from an infected mother.

Globally, about 350 million people are infected with Hepatitis B, with only 1.2 million cases in the United States. Most cases are found in Asia and Africa.

A Freedom of Information Act (FOIA) request of November 9, 2020, for ‘documentation sufficient to reflect any case(s) of transmission of Hepatitis B in an elementary, middle, or high school setting.’ A search of our records failed to reveal any documents pertaining to your request.

​Unless their mothers harbor the virus (determined by routine prenatal blood testing [Surface Antigen Test), newborns are probably the least likely human beings on the planet at risk of actually getting hepatitis B.

In 1996 only 54 cases of the disease were reported to the CDC in the 0-1 age group. There were 3.9 million births that year, so the observed incidence of hepatitis B in the 0-1 age group was just 0.001%. In the Vaccine Adverse Event Reporting System (VAERS), there were 1,080 total reports of adverse reactions from hepatitis B vaccine in 1996 in the 0-1 age group, with 47 deaths reported. Total VAERS hepatitis B reports for the 0-1 age group outnumber reported cases of the disease 20 to 1.

According to the Department of Health and Human Services (HHS), the groups most at risk include intravenous drug users and men who have unprotected sex with other men. In the U.S., the highest rates of chronic Hepatitis B infection are among foreign-born individuals, particularly those from Asia, the Pacific Islands, and Africa.

Theoretically, the Hepatitis B vaccine should help prevent the spread of the disease as it is communicable. However, the vaccine's effectiveness is sometimes debated. According to the Physicians’ Desk Reference, the duration of the protective effect is unknown. The CDC states that the vaccine is 95% effective, but other studies suggest this efficacy may be overstated. Additionally, avoiding high-risk activities, such as unprotected sex with Hepatitis B-positive individuals and using dirty needles, provides protection.

Approximately 95% of individuals infected with Hepatitis B recover completely and gain lifelong immunity. For the remaining 5%, the virus can lead to serious complications, such as liver cancer or cirrhosis, over 20 to 40 years. Acute infections result in death in about 0.2% of cases.

Symptoms of Hepatitis B can vary from mild to severe, including:

• Loss of appetite
• Nausea and vomiting
• Fever
• Fatigue
• Flu-like symptoms
• Dark urine
• Jaundice
• Pale stools
• Itching
• Enlarged liver

Treatment options include rest, avoiding alcohol, interferon, and hyperimmune globulin.

​Chronic Hepatitis B infection can lead to severe complications such as liver cancer, cirrhosis, and potentially death.

While the CDC claims the vaccine is 95% effective, the true efficacy may be lower. Routine booster doses are not generally recommended as the duration of the vaccine's protective effect is uncertain.

The Hepatitis B vaccine is especially beneficial for high-risk groups, such as IV drug users and those engaging in unsafe, unprotected sex with multiple partners. These individuals should carefully consider the risks and benefits of vaccination.

Engerix-B (GSK)

• Active Ingredients: 10 mcg HBsAg for pediatric/adolescent dose, 20 mcg HBsAg for adult dose.
• Adjuvants: 0.25 mg aluminum as aluminum hydroxide (pediatric/adolescent), 0.5 mg aluminum as aluminum hydroxide (adult).
• Excipients: Sodium chloride, phosphate buffers (disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate).

Recombivax (Merck)

• Active Ingredients: Hepatitis B surface antigen (HBsAg).
• Adjuvants: 0.5 mg aluminum (as amorphous aluminum hydroxyphosphate sulfate).
• Excipients: Yeast (genetically modified), residual formaldehyde (<15 mcg/mL).

Toxic Ingredients

• Formaldehyde: Recognized as highly toxic and is an eye, skin, and respiratory tract irritant. Children may be more susceptible than adults to the respiratory effects of formaldehyde. Formaldehyde solution (formalin) causes corrosive injury to the gastrointestinal tract, especially the pharynx, epiglottis, esophagus, and stomach. The systemic effects of formaldehyde are due primarily to its metabolic conversion to formate, and may include metabolic acidosis, circulatory shock, respiratory insufficiency, and acute renal failure. Formaldehyde is a potent sensitizer and a probable human carcinogen.
• Aluminum: Known for its neurotoxic effects, aluminum exposure has been linked to conditions like Alzheimer’s disease. High levels can cause brain and bone diseases, especially in children with kidney issues. 

According to the CDC, one significant concern linked to following the childhood vaccination schedule is the risk of persistent asthma due to aluminum exposure. Aluminum, the most common vaccine adjuvant, is present in many vaccines, including the hepatitis B vaccine. Despite its known neurotoxicity, manufacturers add aluminum to vaccines to create an enhanced inflammatory response that theoretically generates higher protective antibodies.

However, an increasing number of parents are concerned that repeated exposure to vaccines containing aluminum may be harming their children. Indeed, previous animal studies have demonstrated that aluminum increases the risk of allergy by inducing a T helper 2 (Th2) cell-biased immune response. In simpler terms, aluminum causes T cells to become overactivated, exacerbating allergic responses. This overactivation is known to affect airway inflammation and the hyperresponsiveness observed in children with allergic asthma.
​
A study conducted in January involving 326,991 children born from 2008 to 2014 aimed to assess the association between cumulative aluminum exposure from vaccines before age 24 months and persistent asthma at ages 24 to 59 months. The study found a 1.26- and 1.19-times higher risk of persistent asthma for each additional milligram of vaccine-related aluminum exposure. While the observational study stopped short of proving a definitive link between aluminum-containing vaccines and asthma, it highlighted a concerning correlation.

Despite these findings, the CDC has stated that it has no intention of altering its vaccine recommendations based on this study alone. However, the researchers pointed out a notable trend: rates of asthma in U.S. children steadily increased in the 1980s and 1990s and then remained steady since 2001. This date is significant because most aluminum-containing vaccines were added to the childhood vaccine schedule before 2001. These vaccines include, for example, diphtheria, tetanus and acellular pertussis (DTaP), hepatitis B, some formulations of Haemophilus influenzae type b (Hib), and pneumococcal conjugate vaccines.
​
The persistence of asthma rates and the correlation with the introduction of aluminum-containing vaccines raise important questions about the long-term safety of these adjuvants in childhood immunizations. 

And that's not all the harm aluminum causes! Researchers have observed aluminum induces neurotoxic and neuroinflammatory effects (e.g. microglial activation) from dosages of aluminum adjuvants lower than or approximately equal to dosages received by infants according to the CDC vaccine schedule. Additionally, vaccines have been demonstrated to cause immuneactivation brain injury. These studies reveal that early-lifeimmune activation is a causal factor in autism and other neurodevelopmental disorders and mental illnesses (e.g. schizophrenia). The accumulating evidence indicates that vaccine-induced immune activation, and aluminum adjuvants in particular, may cause mental illnesses and neurodevelopmental disorders, including autism.

The HBV vaccine (Merck & GSK) was never tested against a true placebo, which is necessary to determine a safety profile risk prior to licensure.

Epidemiological and mechanistic evidence makes it clear that yeast proteins in HBV vaccines can cause numerous autoimmune disorders, including Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), hypothyroidism, vitiligo and narcolepsy​.

Recombivax (Merck)  - safety review after injection = 5 days
The package insert for Merck’s Recombivax lists a range of potential side effects:

• Severe Allergic Reactions: Anaphylactic/anaphylactoid reactions, bronchospasm, urticaria.
• Musculoskeletal Issues: Arthralgia/arthritis (usually transient), muscle weakness, pain in extremities.
• Neurological Disorders: Guillain-Barré syndrome, multiple sclerosis, exacerbation of multiple sclerosis, myelitis (including transverse myelitis), seizure, febrile seizure, peripheral neuropathy (including Bell’s Palsy), radiculopathy, encephalitis, migraine.
• Skin Conditions: Erythema multiforme, ecchymoses, erythema nodosum, Stevens-Johnson syndrome, petechiae, eczema, alopecia.
• Systemic Issues: Systemic lupus erythematosus (SLE), lupus-like syndrome, vasculitis, polyarteritis nodosa, elevation of liver enzymes, generalized flushing, erythema, pruritic plaques, scleroderma-like lesions.
• Other Conditions: Fever, gastrointestinal disorders, dizziness, hypesthesia, dyspnea, visual disturbances, tinnitus, conjunctivitis, optic neuritis, uveitis, syncope, tachycardia.

Engerix-B (GlaxoSmithKline)  - safety review after injection = 4 days
The package insert for GlaxoSmithKline’s Engerix-B lists these side effects:

• Neurological Issues: Dizziness, headache, encephalitis, encephalopathy, migraine, multiple sclerosis, neuritis, neuropathy (including hypoesthesia, paresthesia, Guillain-Barré syndrome, Bell’s palsy), optic neuritis, paralysis, paresis, seizures, syncope, transverse myelitis.
• Allergic Reactions: Anaphylactoid reaction, anaphylaxis, hypersensitivity syndrome (serum sickness-like), urticaria, erythema multiforme, erythema nodosum, angioedema.
• Musculoskeletal Issues: Arthralgia, back pain, myalgia, muscular weakness, pain/stiffness in arm, shoulder, or neck, arthritis.
• Skin Conditions: Erythema, petechiae, pruritus, rash, sweating, eczema, lichen planus, purpura, Stevens-Johnson syndrome.
• Systemic Issues: Lymphadenopathy, anorexia, agitation, insomnia, somnolence, tingling, flushing, hypotension, gastrointestinal issues (abdominal pain/cramps, constipation, diarrhea, nausea, vomiting), injection site reactions (erythema, induration, swelling, ecchymosis, pain, pruritus), upper respiratory tract illnesses, malaise, weakness, influenza-like symptoms, abnormal liver function tests, apnea, bronchospasm, dyspnea, conjunctivitis, keratitis, visual disturbances, earache, tinnitus, vertigo, palpitations, tachycardia, vasculitis.

The VAERS has documented various adverse events following Hepatitis B vaccination. Although vaccines are generally safe, the National Vaccine Injury Compensation Program (VICP) acknowledges and compensates for vaccine injuries. Since 1988, 279 lawsuits related to the Hepatitis B vaccine have been successful, highlighting the potential for serious side effects.

The persistent failure of neonatal Sudden Infant Death Syndrome (SIDS) rates to decline, coinciding with the increased administration of the birth dose of the hepatitis B vaccine, raised significant concerns. This prompted an investigation, particularly given the report by Silvers et al. which indicated that some infant deaths initially reported to VAERS as SIDS between July 1990 and June 1997 would not meet the current SIDS case definition.
​
From 1992 to 2002, 170 reports related to neonatal hepatitis B vaccination were filed with VAERS in New Hampshire. Of these, 38 reports (22.4%) concerned deaths, with 29 cases remaining unexplained. Within these, 24 deaths were classified as SIDS according to the United States National Vital Statistics, while 4 were attributed to unknown causes.

Preterm infants, particularly those with a birth weight below 2000 grams, have a reduced immune response to the hepatitis B vaccine. Consequently, it is recommended to delay vaccination until these infants reach the age of one month to ensure a more effective immune response.

In addition to the death reports, there were 11 reports of emergency room visits following vaccination with hepatitis B vaccine lot 2612A2. By the end of 2002, there were also 30 VAERS reports indicating cerebral edema after the administration of the hepatitis B vaccine, either alone or in combination with other vaccines. Over the same period, from January 1992 to December 2002, VAERS received approximately 60 reports of bleeding and about 700 reports listing liver problems following hepatitis B vaccination.

These findings highlight the need for ongoing surveillance and evaluation of vaccine safety, particularly in vulnerable populations such as preterm infants. The data underscores the importance of careful consideration and adherence to vaccination guidelines to minimize adverse effects and ensure the health and safety of all infants.

Recent research (2016) has raised concerns about the neurological impacts of the Hepatitis B vaccine, particularly in early developmental stages. A notable study involving mice demonstrated that those vaccinated with the HBV vaccine exhibited significant behavioral changes. The vaccinated mice, referred to as HBV mice in the study, showed a marked decrease in locomotion, indicating reduced physical activity. Additionally, these mice displayed increased anxiety levels, a concerning behavioral shift that highlights potential neurological disturbances caused by the vaccine.

One of the most striking findings from the study was the significant increase in the cytokine IL-6 levels in the HBV mice. IL-6 is a biomarker that has been associated with various neurological conditions, including autism. The elevated IL-6 levels in the vaccinated mice suggest a possible link between the HBV vaccine and neuroinflammatory processes, which could contribute to the development of neuropsychiatric disorders.

The study authors were particularly troubled by the latency period observed in the onset of neurological symptoms. The adverse effects on behavior and neurogenesis in the hippocampus did not manifest immediately but appeared after a considerable delay post-vaccination - it takes time for the side effects to appear. This latency is significant because it suggests that the current short-term monitoring periods used in vaccine trials may not be sufficient to detect all potential adverse effects. The authors noted the complexity of the mechanisms underlying this delayed response, indicating a need for further research to fully understand the immune and neural interactions at play.

The conclusions drawn by the study authors are compelling and call for a reevaluation of the current vaccination practices, especially in neonates. The study's findings suggest a potential association between early HBV vaccination and the development of neuropsychiatric disorders such as autism and multiple sclerosis. The authors explicitly state that their work reveals, for the first time, the impairments in behavior and hippocampal neurogenesis induced by early HBV vaccination.

This study underscores the critical role of animal research in understanding the neurotoxic effects of vaccine adjuvants. A recent editorial by a group of scientists emphasized that animal studies are crucial for identifying neuro/immunologic adverse effects that are difficult to establish through epidemiological studies alone. Epidemiology, which relies on large-scale data analysis, can often miss subtle but significant health outcomes. Therefore, biological science and animal studies, like the one conducted by Dr. Yao and his colleagues, are essential for a comprehensive assessment of vaccine safety.

​The evidence presented in this study provides a substantial challenge to the assumption that vaccines, including the HBV vaccine, are entirely safe with regard to neurological health. The observed behavioral changes, cytokine spikes, and delayed onset of symptoms in vaccinated mice suggest that more extensive and long-term studies are necessary. These findings highlight the importance of reconsidering the current vaccination protocols and ensuring that safety assessments are thorough and adequately long-term. As the debate over vaccine safety continues, studies like this serve as a crucial reminder of the potential complexities and risks involved in immunization practices.

Recent findings indicate that U.S. male neonates vaccinated with the hepatitis B vaccine before 1999 faced a significantly higher risk of being diagnosed with autism. Specifically, these boys had a threefold increased risk of an autism diagnosis reported by their parents compared to those who were not vaccinated as neonates during the same period.
​
The risk was particularly pronounced among nonwhite boys, suggesting that racial disparities might play a role in vaccine-related outcomes. This data underscores the need for thorough investigation into the potential long-term effects of neonatal hepatitis B vaccination and highlights the importance of considering demographic factors when assessing vaccine safety and efficacy.

The CDC advises consulting with a healthcare provider before vaccination if there has been an allergic reaction to a previous dose, any severe allergies (to yeast or heavy metals), or if the individual is moderately or severely ill. Newborns, who are neither IV drug users nor sexually active, are often deemed not to be at significant risk for Hepatitis B and may not be ideal candidates for this vaccine, given the risks associated with all medical procedures, including vaccinations.

It is undeniable, the Hepatitis B vaccine contains ingredients that pose potential risks. Both Recombivax and Engerix-B list significant side effects and contain aluminum and formaldehyde, which have known toxicities. The administration of the Hepatitis B vaccine to newborns should be carefully considered. Evaluating the risks and benefits, understanding potential side effects, and considering lifestyle factors are essential steps in making an informed decision about the Hepatitis B vaccine.

Infants, toddlers, and young children who receive the hepatitis B vaccine face minimal risk of contracting hepatitis B, yet they are subjected to significant potential risks. These risks include the development of neurodevelopmental disorders, autoimmune illnesses, and even the possibility of death.

For children in the 0-1 age group, the ratio of reported vaccine injuries and deaths associated with the hepatitis B vaccine to actual cases of hepatitis B infection is at least 20:1. This stark disparity raises serious questions about the constitutionality of mandating hepatitis B vaccination for populations with little to no risk of contracting the disease.
​
Mandates for hepatitis B vaccination in these young populations fail to respect the principles of personal liberty, equal protection under the law, and the health rights of the children. The imposition of such mandates without sufficient justification for the targeted age group undermines the protection of individual freedoms and raises ethical and legal concerns.

“ATSDR - Public Health Statement: Aluminum.” Web.archive.org, 13 Mar. 2020, web.archive.org/web/20200313041154/www.atsdr.cdc.gov/phs/phs.asp?id=1076&tid=34. 

ENGERIX-B [Hepatitis B Vaccine (Recombinant)] . www.fda.gov/media/119403/download.

RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant). www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/package-insert-recombivax-hb.pdf.

“Drug Summary.” Www.pdr.net, www.pdr.net/drug-summary/?drugLabelId=Recombivax-HB-hepatitis-B-vaccine--recombinant--383. 


“Hepatitis B at Risk.” Archive.org, 2024, web.archive.org/web/20170221214342/www.cdc.gov/hepatitis/hbv/pdfs/hepbatrisk.pdf. 

“Hepatitis B Basics.” HHS.gov, 30 Jan. 2019, www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.html.

​Arumugham, Vinu. Bioinformatics and Epidemiological Evidence Link Yeast Protein Containing HPV and Hepatitis B Vaccines to Numerous Autoimmune Disorders such as Vitiligo, Narcolepsy, Hypothyroidism, Systemic Lupus Erythematosus and Rheumatoid Arthritis. Nov. 2018, childrenshealthdefense.org/wp-content/uploads/Arumugham-2018-Bioinformatics-and-epidemiological-evidence-link-yeast-protein-containing-HPV.pdf.

Brehm, Elizabeth. FOIA - Hepatitis B Transmission. 2020 https://icandecide.org/wp-content/uploads/2022/12/CDC-FOIA-response-showing-no-hep-b-cases-transmitted-in-schools.pdf 

Yang, Junhua, et al. “Neonatal Hepatitis B Vaccination Impaired the Behavior and Neurogenesis of Mice Transiently in Early Adulthood.” Psychoneuroendocrinology, vol. 73, 1 Nov. 2016, pp. 166–176, www.sciencedirect.com/science/article/pii/S0306453016305145?casa_token=xj3nJbD0jGEAAAAA:MJHQTcz5-vuKZp1g-uMiO6rmrVOmFufr83io_SGypMR99W4ri9GYc6WwSVenOuIH3pBk08dC, https://doi.org/10.1016/j.psyneuen.2016.08.002. 

Soldatenkova, Valentina A, and F. Edward Yazbak. “An Investigation of Infant Deaths Following Initial Hepatitis B Vaccination Based on the Vaccine Adverse Event Reporting System (VAERS), 1992-2002.” Medical Veritas, vol. 4, 1 Jan. 2007. 
​
Gallagher, Carolyn M., and Melody S. Goodman. “Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997–2002.” Journal of Toxicology and Environmental Health, Part A, vol. 73, no. 24, 29 Oct. 2010, pp. 1665–1677, https://doi.org/10.1080/15287394.2010.519317.

​Belkin , Michael. “Michael Belkin Testimony to Congress.” Whale.to, 1999, whale.to/vaccines/belkin.html. Accessed 13 June 2024.

​HogenEsch, Harm. “Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants.” Frontiers in Immunology, vol. 3, no. 406, 10 Jan. 2013, www.ncbi.nlm.nih.gov/pmc/articles/PMC3541479/, https://doi.org/10.3389/fimmu.2012.00406.

​“T Helper 2 Cell Overview - US.” Www.thermofisher.com, www.thermofisher.com/us/en/home/life-science/cell-analysis/cell-analysis-learning-center/immunology-at-work/t-helper-2-cell-overview.html.

​Daley, Matthew F., et al. “Association between Aluminum Exposure from Vaccines before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.” Academic Pediatrics, vol. 23, no. 1, 2023, pp. 37–46, pubmed.ncbi.nlm.nih.gov/36180331/, https://doi.org/10.1016/j.acap.2022.08.006. Accessed 13 Feb. 2024.

​Exley, Christopher. “What Is the Risk of Aluminium as a Neurotoxin?” Expert Review of Neurotherapeutics, vol. 14, no. 6, 30 Apr. 2014, pp. 589–591, https://doi.org/10.1586/14737175.2014.915745.

Newborns are exposed to aluminum through various sources, including vaccines and the vitamin K shot administered shortly after birth. Aluminum is used as an adjuvant in many vaccines to enhance the immune response. However, the package insert for Pfizer’s vitamin K formulation explicitly warns that the product "contains aluminum that may be toxic," and notes that "premature neonates are particularly at risk." Despite this warning, it is common practice to administer vitamin K shots to preterm infants, raising significant safety concerns.

Despite its widespread use, the vitamin K injection has faced criticism from some quarters. Critics argue that the risk of VKDB is minimal and that the injection, which contains synthetic vitamin K (phytonadione) and other additives (including aluminum), may pose potential risks to infants.

​Reported side effects include:

• Cardiac Disorders: Tachycardia, hypotension
• General Disorders: Generalized flushing, pain, swelling, and tenderness at the injection site
• Hepatobiliary Disorders: Hyperbilirubinemia
• Immune System Disorders: Fatal hypersensitivity reactions, anaphylactic reactions
• Neurologic: Dysgeusia, dizziness
• Pulmonary: Dyspnea
• Skin and Subcutaneous Tissue Disorders: Erythema, pruritic plaques, scleroderma-like lesions, erythema perstans
• Vascular: Cyanosis

Deaths have occurred after intravenous and intramuscular administration​.

Additionally, there is a risk of hemolysis, jaundice, and hyperbilirubinemia, particularly in premature infants, if an overdose of phytonadione injectable emulsion occurs.

Vitamin K is a fat-soluble vitamin essential for several bodily functions, including blood clotting and bone health. It exists in two primary forms: Vitamin K1 (phylloquinone) and Vitamin K2 (menaquinone). Both forms play distinct roles in the body.

Functions of Vitamin K1 (Phylloquinone)

• Blood Clotting (Coagulation)
  1. Activation of Clotting Factors: Vitamin K1 is crucial for the synthesis of several proteins that mediate coagulation, particularly prothrombin (factor II) and factors VII, IX, and X. These proteins are essential for blood clotting and wound healing .
  2. Conversion to Active Forms: It helps convert these clotting factors into their active forms, which can bind calcium ions and participate in the clotting cascade.
• Osteocalcin Activation: Vitamin K1 assists in the carboxylation of osteocalcin, a protein necessary for binding calcium to the bone matrix, thereby contributing to bone mineralization and strength .
• Regulation of Calcification: Vitamin K1 also helps prevent the calcification of blood vessels, reducing the risk of cardiovascular diseases by regulating proteins like matrix Gla-protein (MGP), which inhibit vascular calcification .

Functions of Vitamin K2 (Menaquinone)

• Activation of Clotting Factors: Both MK-4 and MK-7 play crucial roles in the synthesis of proteins required for blood clotting, such as prothrombin. This function is essential for preventing excessive bleeding.
• Reduction of Inflammation: Some studies suggest that vitamin K2 has anti-inflammatory properties, which may help reduce the risk of chronic inflammatory diseases.
• Cellular Growth and Health: MK-4, in particular, is involved in the regulation of cellular growth and apoptosis (programmed cell death), playing a role in cancer prevention and overall cellular health.
• Bone Health
  1. Enhancement of Osteocalcin: Similar to K1, Vitamin K2 plays a crucial role in bone health by aiding the carboxylation of osteocalcin. This form of Vitamin K is particularly effective in supporting bone density and reducing the risk of fractures .
  2. Support for Bone Formation: It also stimulates bone formation by enhancing the function of osteoblasts, the cells responsible for building new bone tissue .
• Prevention of Arterial Calcification: Vitamin K2 is known for its role in reducing arterial stiffness and preventing calcification of arteries, which can help lower the risk of atherosclerosis and related cardiovascular conditions .
• Metabolic and Hormonal Health
  1. Regulation of Glucose Metabolism: Some studies suggest that Vitamin K2 can improve insulin sensitivity and reduce the risk of type 2 diabetes by enhancing glucose metabolism .
  2. Hormonal Balance: K2 has also been implicated in the regulation of sex hormones, contributing to reproductive health and overall hormonal balance .​

Both forms of Vitamin K have been shown to support detoxification processes indirectly through their roles in overall health maintenance:

• Support Liver Function: The liver is the primary site for Vitamin K storage and use, particularly in producing clotting factors. By supporting liver function, Vitamin K can help maintain efficient detoxification processes .
• Antioxidant Properties: Vitamin K has antioxidant properties, which can protect cells from oxidative stress and damage, a key component of effective detoxification .

​Overall, both Vitamin K1 and K2 are vital for maintaining various physiological processes, with each form offering unique benefits that contribute to overall health.

Advocates for a more natural approach suggest that proper maternal nutrition during pregnancy can help ensure adequate vitamin K levels in newborns. A diet rich in natural vitamin K from sources such as green leafy vegetables, fermented foods, and animal products is recommended. Colostrum, the first form of breast milk, is also naturally rich in vitamin K and can help boost the newborn's levels.

Natural Sources of Vitamin K1 (Phylloquinone)
Vitamin K1 is primarily found in green leafy vegetables. Some of the best sources include:

1. Kale
2. Spinach
3. Collard Greens
4. Swiss Chard
5. Turnip Greens
6. Broccoli
7. Brussels Sprouts
8. Cabbage
9. Green Tea
10. Herbs (Cilantro, Parsley)

Natural Sources of Vitamin K2 (Menaquinone)
Vitamin K2 exists in several subtypes, with MK-4 and MK-7 being the most studied and understood. Vitamin K2 is found in certain animal products and fermented foods.
MK-4 (Menaquinone-4)

• Animal Products:
  1. Liver: Beef, pork and chicken liver are rich in MK-4.
  2. Egg Yolks: A significant source of MK-4.
  3. Dairy Products: Full-fat (ideally raw and pasture-raised) dairy products such as butter, cheese, and whole milk.
  4. Fish (Salmon, Mackerel)
  5. Chicken: Particularly the dark meat.

MK-7 (Menaquinone-7)

• Fermented Foods:
  1. Natto: Fermented soybeans are the richest source of MK-7.
  2. Fermented Vegetables: Foods like sauerkraut and kimchi can contain MK-7.
  3. Cheeses: Certain fermented cheeses, such as Gouda, Jarlsberg, and Edam, are good sources of MK-7.
  4. Fermented Dairy Products (Kefir, Yogurt)​

​Incorporating these foods into a diet can help ensure adequate intake of both vitamin K1 and K2, supporting overall health and specific functions such as blood clotting and bone health.

Miller NZ, Goldman GS. Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity? Human & Experimental Toxicology. 2011;30(9):1420-1428. doi:10.1177/0960327111407644

Y. de Vries J, Pundir S, Mckenzie E, Keijer J, Kussmann M. Maternal Circulating Vitamin Status and Colostrum Vitamin Composition in Healthy Lactating Women—A Systematic Approach. Nutrients. 2018; 10(6):687. https://doi.org/10.3390/nu10060687

https://labeling.pfizer.com/ShowLabeling.aspx?id=5392​

​Shaw, C. A., & Tomljenovic, L. (2013). Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunologic Research, 56, 304-316.

Supporting regenerative practices doesn't just benefit the environment; it has a positive ripple effect contributing to the economic sustainability of local economies. By fostering connections between consumers and producers, these practices create economic sustainability within communities. This model encourages responsible land stewardship and promotes a sense of shared responsibility for the environment.

Regenerative animal husbandry, especially in pasture-raised systems, offers a holistic and sustainable approach to managing large grasslands. By focusing on soil health, biodiversity, and thoughtful grazing management, these practices contribute to carbon sequestration, mitigate methane emissions, and promote the overall resilience of ecosystems. As we face the challenges of climate change, harnessing the power of regenerative animal husbandry emerges as a vital strategy for a more sustainable and balanced future.

Even the Big Techers admit it: social media is ripping apart the fabric of our society. So the solution is simple, right? Delete your social media! Or is it not that simple? Join James Corbett on this edition of #SolutionsWatch as he explores the solutions to the Media Matrix problem.

Forming community with like-minded people has never been more important . . . and it has never been more difficult. As the gatekeepers of our increasingly disconnected world try to close the door on our various options for finding community, today James explores some ways to meet sane people in your area, from the technological to the old-fashioned.​

The Grand Leader of The Technofascist Great Reset, Klaus Schwab, has issued his pronouncement: our digital infrastructure (and even the power grid that enables it) is at great risk of global disruption from cyberattack. And you know what? He’s right. It’s just that the most likely cyberterrorists are the criminals in government and in organizations connected to the World Economic Forum. In any case, we shouldn’t rely on the idea of important information being forever and always available at the click of a button. So what ever can we do to safeguard the books, music and media that we hold dear? What people have always done: keep a physical copy of it. Today James and his guests extol the virtues of physical media in an increasingly digital age.

Welcoming Remarks. Klaus Schwab
About Cyber Polygon
Cyber Polygon 2020 full livestream
What I Learned From the Master of Propaganda – #PropagandaWatch
Cybercrime is maturing. Here are 6 ways organizations can keep up
“Next Crisis Bigger than COVID” – Power Grid/Finance Down – WEF’s Cyber Polygon
When False Flags Go Virtual
An EMP False Flag
The Photo Book That Captured How the Soviet Regime Made the Truth Disappear
Episode 384 – The Library of Alexandria is on Fire
And Then They Came for the Books…
The Church of the Holy State
“Anarchy” by Richard T. Ely
Launch of HathiTrust – October 13, 2008
How does HathiTrust Emergency Temporary Access Service (ETAS) work? Why can’t I check out a physical copy of a HathiTrust item if it is in the Libraries’ collections?
Episode 360 – Steal This Podcast (Please!)
Grand Theft World Podcast 005 | Unmasking Dystopia
Amazon Secretly Removes “1984” From the Kindle

Derrick Broze of TheConsciousResistance.com joins us today to provide an update on the counter-economic underground railroad which we discussed last year. The first group has crossed the border and more people than ever are looking to escape the Collapsing States of America and finding freedom elsewhere. We discuss the exit and build strategy, Freedom Cells, and how you can find out more about the growing number of people who are looking to start communities of purpose.

Transcript:

I'm a conspiracy theorist.
A radical extremist.
A paranoid ridiculous delusional idealist.
I'm a ludicrous anarchist.
I'm a pessimistic communist.
I'm a woowoo hippie dippie foil hat enthusiast.

Agrarianism is a socio-economic and political philosophy that places a significant emphasis on agriculture, rural life, and the well-being of farming communities. The term is derived from the Latin word "ager," which means "field" or "land." Agrarianism advocates for the importance of agriculture as the foundation of a healthy and sustainable society.

Agrarianism promotes countryside living over an urbanized lifestyle. It is a rejection of capitalism which it sees as damaging to rural and farming communities. Instead it advocates for these communities to be more self-sufficient living off local and sustainable produce. It's origins lie within a 19th century European movement which gave voice to peasants and farmers during the period of Industrial Revolution. In the 21st century however Agrarians favored decentralization of government, the promotion of traditional values, and fair rights in pay for farmers and farm workers.

Key principles of agrarianism include:

1. Agricultural Focus: Agrarianism prioritizes the cultivation of the land and views agriculture as the backbone of the economy. It recognizes the value of sustainable farming practices and the role of farmers in providing essential resources.
2. Rural Vitality: The philosophy promotes the well-being of rural communities, emphasizing the importance of preserving the social fabric and cultural heritage of countryside areas. Agrarianism often contrasts with urbanization and industrialization.
3. Localism: Agrarianism supports local economies and self-sufficiency. It encourages communities to produce and consume goods locally, reducing dependence on external sources and fostering a sense of autonomy.
4. Stewardship of the Land: Agrarianism values responsible land stewardship, emphasizing the need to conserve natural resources and maintain the health of the environment for future generations.
5. Resistance to Industrialization: Historically, agrarianism has been critical of industrialization, seeing it as a threat to rural life, agricultural traditions, and the environment. This perspective often reflects a preference for small-scale, family-owned farms.
6. Community Interdependence: Agrarian communities are seen as interconnected and interdependent, with a focus on shared responsibilities and cooperation. This sense of community extends beyond economic concerns to encompass social and cultural aspects.

Agrarianism has influenced various movements throughout history, including populist movements, environmentalism, and critiques of modern industrial society. It continues to shape discussions about sustainable agriculture, rural development, and the balance between technological progress and environmental stewardship.

Our ancestors have used mushrooms as medicine for thousands of years. The Greek physician
Hippocrates, 450 BCE, classified the amadou mushroom (Fomes fomentarius) as a potent anti-inflammatory and for cauterizing wounds. Although mushrooms have long been used by various cultures, only recently has modern science rediscovered what the ancients knew long ago—that mushrooms can be deep reservoirs of powerful medicines (Stamets & Zwickey, 2014).

Indeed, it is well established that both the human population and Mother Earth could benefit from the existence of mushrooms which could one day save the world. From fulfilling our macro-nutrient needs to increasing our immune system in order to fight off viruses & diseases (Stamets, 2009; 2012).

Some mushrooms, however, are now under clinical trials due to their mind altering effects which has the potential to cure a number of mental health disorders such as depression, addiction, and anxiety with many more results soon to come. And as long as there are organizations who are allowed to study any psychedelics with medicinal uses, then it could very possibly be that they have been part of our evolution for thousands of years (Jr, 2017; Mcrae, 2017; Thomas, Malcolm & Lastra, 2017).

Mycelium is the roots of white fuzzy threads or network where mushrooms spawn. Paul Stamets has briefly explained on Fungi the impact mycelium has on our ecology

Four components of mycorestoration are described in detail:

• Mycofiltration: the filtration of biological and chemical pathogens as well as controlling erosion
• Mycoforestry and mycogardening: the use of mycelium for companion cultivation for the benefit and protection of plants.
• Mycoremediation: the use of mycelium for decomposing toxic wastes and pollutants.
• Mycopesticides: the use of mycelium for attracting and controlling insect populations. (Stamets, 2005)

These hardwood dowels, or “plug spawn”, have been inoculated with a single species of fungi. Plug spawn is used to inoculate a fresh cut log to encourage the growth and fruiting of a specific species of edible and/or medicinal mushroom. Plug spawn can be stored in the refrigerator for up to 4-6 months before use.

After the incubation period, logs can be soaked to force a fruiting.

Soaking Method

• Immerse log in chlorine-free cold water for 12 hours or until logs are fully saturated.
• Stack logs off the ground in a shady area.
• If outdoor humidity levels are low, plastic sheeting can be used as a tent to increase humidity. Avoid logs having contact with the plastic.
  
• When the logs are done fruiting, allow them to rest 8-10 weeks before forcing them to fruit again.

Click the following link for suggestions on burying Nameko, Maitake, and Reishi logs after incubation.

Ballroom, Jr. (2017). Psychedelic Science 2017, Psilocybin Mushrooms and The Mycology of Consciousness. Retrieved 01/16/2019 from http://psychedelicscience.org/conference/interdisciplinary/psilocybin-mushrooms-and-the-mycology-of-consciousness

Mcrae, M. (2017). Science Alert, Research Shows Magic Mushrooms Can Offer Real Benefits in Depression Therapy. Retrieved 01/16/2019 from https://www.sciencealert.com/therapy-for-depression-gets-a-significant-boost-when-combined-with-psilocybin

Stamets, P. (2005). Mycellium running. Berkeley, California,: Ten Speed Press.

Stamets, P. (2009). Fungi Perfecti, The Search for Agarikon. Retrieved 01/16/2019 from http://www.fungi.com/blog/items/the-search-for-agarikon.html

Stamets, P. (2012). The Blog, Agarikon: Ancient Mushroom for Modern Medicine. Retrieved 01/16/2019 from https://www.huffingtonpost.com/paul-stamets/agarikon-mushroom_b_1861947.html

Stamets, P., & Zwickey, H. (2014). Medicinal Mushrooms: Ancient Remedies Meet Modern Science. Integrative medicine (Encinitas, Calif.), 13(1), 46-7. Retrieved 01/16/2019 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684114/pdf/46-47.pdf

Thomas, K., Malcolm, B. and Lastra, D. (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Journal of Psychoactive Drugs. [online] 59(5), pp.446-455. Available at https://dx.doi.org/10.1080/02791072.2017.1320734 [Accessed 16 Jan. 2019]

Dunbar's number is a suggested cognitive limit to the number of people with whom one can maintain stable social relationships—relationships in which an individual knows who each person is and how each person relates to every other person. This number was first proposed in the 1990s by British anthropologist Robin Dunbar, who found a correlation between primate brain size and average social group size. By using the average human brain size and extrapolating from the results of primates, he proposed that humans can comfortably maintain only 150 stable relationships.

Dunbar is an anthropologist at the University College of London, who wrote a paper on Co-Evolution Of Neocortex Size, Group Size And Language In Humans where he hypothesizes:

... there is a cognitive limit to the number of individuals with whom any one person can maintain stable relationships, that this limit is a direct function of relative neocortex size, and that this in turn limits group size ... the limit imposed by neocortical processing capacity is simply on the number of individuals with whom a stable inter-personal relationship can be maintained.

Dunbar supports this hypothesis through studies by a number of field anthropologists. These studies measure the group size of a variety of different primates; Dunbar then correlate those group sizes to the brain sizes of the primates to produce a mathematical formula for how the two correspond. Using his formula, which is based on 36 primates, he predicts that 147.8 is the "mean group size" for humans, which matches census data on various village and tribe sizes in many cultures.

Want to grow fresh veggies and flowers but space is limited? A raised garden bed is a perfect solution. Here's how to make one.

People are isolated from each other, public spaces are being privatized, and we are being punished for attempting to grow our own food. There is only one solution: resistance. Join James for this classic Corbett Report episode where he explores how to build communities through revolutionary gardening, revolutionary walking and other everyday activities.

Using wikis and digital fabrication tools, TED Fellow Marcin Jakubowski is open-sourcing the blueprints for 50 farm machines, allowing anyone to build their own tractor or harvester from scratch. And that's only the first step in a project to write an instruction set for an entire self-sustaining village (starting cost: $10,000).

The most common, man-made, building material is undoubtedly concrete. Each ton of cement produces about 900 kg CO2. But researchers have observed that the addition of hemp fiber to concrete resulted in a high performing, eco-friendly construction material. Hemp is not a new construction material. Archaeologists have confirmed the use of hemp fiber (also called ‘shive’) in the construction of a bridge, dated to the 6th century AD, in southern France. Hemp is a fast-growing plant that has prospect not only in terms of biomass energy recovery, but also of material in the construction field in accordance with the principles of sustainable development.

Hempcrete is non-toxic, bio-composite mixture of hemp shive, lime binder and water. The hemp shive is the wooden part of the hemp stem (approximately 2/3 of stem) in the processing of hemp plant to the fiber. Commonly, it is lime or cement but could be any combination of elements to make a hemp binder. A lightweight material, it is about one eighth the weight of concrete. Hempcrete can be used to construct walls, floors and roofs; or molded (monolithic), sprayed or precast (e.g. hemp bricks or panels). Generally, it is inserted as infill insulation around the structural framing of the house. Often for clarity, hempcrete is referred to as Lime Hemp Composite (LHC).

Like other plant products by photosynthesis, hemp absorbs CO2 from the atmosphere as it grows, retaining the carbon and releasing the oxygen. This process is called carbon sequestration, and involves the capture of carbon and the long-term storage of atmospheric carbon dioxide. It has been proposed as a way to slow the atmospheric and marine accumulation of greenhouse gases.

Even when the hemp shiv is mixed with concrete (80-90% of hemcrete composition as hemp shiv), it is able to still sequester CO2. The lime-based binder absorbs carbon from the air continuously over time, petrifying the hemp shiv. Each tonne of lime-based hempcrete is estimated to absorb and sequester 249 kg of CO2 over a 100 year lifecycle.  Generally, hempcrete is estimated to sequester 110kg per cubic meter (depending on transportation use) which means large-scaled projects have the capabilities of drawing tonnes of CO2 out of the atmosphere.